B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp ADR (NQ: AMRN )

1.890 -0.060 (-3.08%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Amarin Corp ADR

< Previous 1 2 3 4 Next >
Sarissa Capital Highlights Amarin’s Disregard for Shareholder Interests and Urges Shareholders to Vote the BLUE Proxy Card for Change at Amarin
From Sarissa Capital Management LP
Via Business Wire
Amarin Mails Letter to Shareholders Highlighting New Board and Superior Leadership
From Amarin Corporation plc
Via Globe NewsWire
Sarissa Capital Urges Amarin Shareholders to Vote the Blue Card by February 22 to Fix Amarin for the Benefit of Shareholders
From Sarissa Capital Management LP
Via Business Wire
Amarin Files Definitive Proxy Materials and Mails Letter to Shareholders
From Amarin Corporation plc
Via Globe NewsWire
Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand
Marks 7th Regulatory Approval for VASCEPA®/VAZKEPA® Franchise in Key International Markets Since 2022 
From Amarin Corporation plc
Via Globe NewsWire
Amarin to Present at SVB Securities Global Biopharma Conference
From Amarin Corporation plc
Via Globe NewsWire
Amarin Responds to Inaccurate and Misleading Statement by Sarissa
From Amarin Corporation plc
Via Globe NewsWire
Sarissa Capital Calls Out Amarin’s Sham Board Refreshment
From Sarissa Capital Management LP
Via Business Wire
Amarin Comments on Sarissa’s Notice to Call a Special Meeting of Amarin Shareholders
Highlights Significant Board Refreshment, Operational and Financial Improvements and Engagement with Sarissa Capital Management 
From Amarin Corporation plc
Via Globe NewsWire
Sarissa Capital Submits Notice to Call a Special Meeting of Amarin Shareholders to Add Directors and Remove Chairman Per Wold-Olsen
From Sarissa Capital Management LP
Via Business Wire
Amarin Provides Preliminary Fourth Quarter and Full Year 2022 Revenue and Cash Position and Priorities for 2023
From Amarin Corporation plc
Via Globe NewsWire
Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP
From Amarin Corporation plc
Via Globe NewsWire
Amarin to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Amarin Corporation plc
Via Globe NewsWire
Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland
From Amarin Corporation plc
Via Globe NewsWire
Amarin Announces VAZKEPA® (icosapent ethyl) Approved by the Therapeutic Goods Administration (TGA) in Australia
From Amarin Corporation plc
Via Globe NewsWire
Amarin to Present at Jefferies London Healthcare Conference
From Amarin Corporation plc
Via Globe NewsWire
Amarin Highlights Key Data Presented at American Heart Association 2022 Scientific Sessions for VASCEPA®/VAZKEPA (icosapent ethyl) and Patient Care
From Amarin Corporation plc
Via Globe NewsWire
Amarin Reports Third Quarter 2022 Financial Results and Provides Business Update
From Amarin Corporation plc
Via Globe NewsWire
Amarin Appoints Adam Berger and Geraldine Murphy to Board of Directors
From Amarin Corporation plc
Via Globe NewsWire
Amarin to Report Third Quarter 2022 Financial Results And Host Conference Call on October 27, 2022
From Amarin Corporation plc
Via Globe NewsWire
Amarin Board of Directors Issues Statement in Response to Sarissa
From Amarin Corporation plc
Via Globe NewsWire
Sarissa Capital Has Commenced the Process to Call a Special Meeting of Amarin Shareholders to Remove and Replace Certain Board Members
From Sarissa Capital Management LP
Via Business Wire
3 Biotech Stocks Gaining Momentum
The headlines have been particularly good for a trio of small cap biotechs and it appears the momentum may have staying power. 
Via MarketBeat
MarketBeat: Week in Review 8/22 - 8/26
The markets are selling on news that interest rate hikes will continue past September. But here are some of the other stories for investors to follow this week 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Are Ocugen or Amarin Good Penny Stocks to Buy?
This article discusses the current state of Ocugen and Amarin, two penny stocks that highlight the risk and (potential) reward of penny stock investing. 
Via MarketBeat
Does Amarin Deserve a Spot in Your Portfolio after Earnings ?
Amarin recently announced its earnings for Q2'22 with mixed results. Here we'll examine the pros and cons of having this penny stock in your portfolio. 
Via MarketBeat
Topics Earnings
Exposures Financial
Sarissa Capital Intends to Vote “Abstain” at the Amarin Annual Meeting
From Sarissa Capital Management LP
Via Business Wire
NASDAQ:AMRN Long Term Investor Notice: Investigation of Potential Wrongdoing at Amarin Corporation Plc
San Diego, CA -- (SBWIRE) -- 03/09/2022 -- An investigation was announced for investors in shares of Amarin Corporation plc (NASDAQ:AMRN) concerning potential breaches of fiduciary duties by certain... 
Via SBWire
NASDAQ: AMRN Investor Notice: Deadline on December 23, 2021in Lawsuit Against Amarin Corporation Plc
San Diego, CA -- (SBWIRE) -- 12/16/2021 -- A Deadline is coming up on December 23, 2021 in the lawsuit for certain investors in Amarin Corporation plc (NASDAQ: AMRN). 
Via SBWire
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.